Category Specific RSS

gastric cancer

Imugene partners with multi billion dollar global pharma company, Merck & Co for new trial

Since securing a European patent for their proprietary cancer vaccine HER-Vaxx, Imugene (ASX: IMU) have been busy. The Company has…

3 years ago